Click here
Wednesday 22 May 2013 Register   Login
Search 
  
You are here:
Home
News
Latest issue
Subscribe
Email bulletin
Suppliers Guide
Advertise
Contact us
New neurology product
Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here
LATEST ISSUE
Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Featured Articles

Benefits and cost-effectiveness of Nivestim™ for febrile neutropenia

Hospital Pharmacy Europe Issue 62 May/June 2012

Biosimilar medicines have emerged as potentially cost-effective alternatives to originator products. This review focuses on Nivestim™, a filgrastim biosimilar approved for the treatment of febrile neutropenia

You must login to continue reading this article


Forgotten your password? Click this button and we will send you a reminder by email.

Password reminder


Not yet registered?
Register now - you will get instant access to this article and many hundreds of others.

Register now


Need advice? Try the help section.
USER TOOLS
Have your say - comment on this item
Print-friendly version
© Campden Publishing Limited 2013
Site Map | Accessibility | Terms & Conditions | Privacy Policy | Contacts
Campden Publishing Ltd., 140 London Wall London EC2Y 5DN, is a company registered in the United Kingdom with Reg. No. 2147432
www.campden.com

Web design, hosting and programming by ModeZero